Agile Thinking

Share this post

User's avatar
Agile Thinking
Paxlovid Weaker Against Current COVID-19 Variants
Health

Paxlovid Weaker Against Current COVID-19 Variants

Printed for doctors to read in the conservative Medscape Journal from Sept. 22, 2023

devaki berkson's avatar
devaki berkson
Oct 03, 2023
∙ Paid
2

Share this post

User's avatar
Agile Thinking
Paxlovid Weaker Against Current COVID-19 Variants
Share

A real-world study published in  JAMA Open Network  found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared to earlier studies. But when looking at death alone, the antiviral was still highly effective. 

Paxlovid was about 37% effective at preventing death or hospitali…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Dr. Devaki Lindsey Berkson
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share